by Eric Christianson | Jun 16, 2019 | Long Term Care Consultant Pharmacist Education and Information
I really enjoy receiving questions from other pharmacists and students. On LinkedIn, I recently received the question, “What’s it like being a consultant pharmacist? First, I do want to mention that there may be many different interpretations of what a...
by Eric Christianson | Jun 12, 2019 | Medication and Disease State Clinical Pearls For Pharmacists, Renal, Urology, and Electrolytes Medication and Disease State Clinical Pearls
If you have ever had a patient that has had a substantially elevated potassium level, you have likely been very nervous about their medication list. I really start to get concerned when I see levels above 6 mEq/L. There are numerous drugs that affect potassium that...
by Eric Christianson | Jun 5, 2019 | Cardiovascular Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
As a healthcare professional, when I hear the term heparin-induced thrombocytopenia (HIT), I get nervous. The classically taught heparin-induced thrombocytopenia (type 2) is very serious. HIT is something that needs to be closely watched for because consequences from...
by Eric Christianson | Jun 2, 2019 | NAPLEX
It is NAPLEX and MPJE season. It’s a time of year that is full of anticipation, fear, excited, joy, and for some, anguish. Failing the NAPLEX or the MPJE was my biggest fear and I have heard from many who have failed one of these exams and been unable to obtain...
by Eric Christianson | May 29, 2019 | Drug Interaction Case Studies and Education For Pharmacists
The albuterol beta-blocker interaction is real and is significant. But how significant is it? What questions should you ask yourself? Which Beta-Blocker We Talkin’ Bout? The very first question I would assess is which beta-blocker are we talking about as not all...
